Mar 27, 2024, 06:38 by

IgniteData has been awarded £1/2 million from Innovate UK Smart Grants to fund a transformative clinical research data project. The initiative will focus on providing hospitals and trial sponsors with streamlined access to unstructured healthcare data, delivering efficiencies, reducing costs and improving patient care. The funding will enable IgniteData to build on existing work addressing the challenges around unstructured data (such as diagnoses, clinical procedures and free text notes) and the role of Artificial Intelligence (AI) in enhancing data accessibility for clinical studies.

Mar 27, 2024, 06:00 by User Not Found

Clinical Research News | SEQSTER has been selected by the Multiple Sclerosis Association of America (MSAA) for its patient-centricity, 1-Click Records, and cutting-edge longitudinal health record; Owkin adds immunology to Sanofi collaboration; Thermo Fisher Scientific launches a new CorEvitas syndicated clinical registry in generalized pustular psoriasis; and more.

Mar 26, 2024, 07:56 by

CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), - due to launch to the market in June 2024 – and was developed collaboratively, based on market needs, with two large pharmaceutical clients of CluePoints who helped provide direction and feedback regarding the required features and functionalities.

Mar 26, 2024, 07:56 by

Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite.

Mar 26, 2024, 06:00 by User Not Found

Clinical Research News | Sionna Therapeutics plan to develop a first-in-class small molecules designed to fully restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein by stabilizing the first nucleotide-binding domain (NBD1); Capstan Therapeutics is advancing CPTX2309, the company’s lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, to early clinical proof-of-concept in autoimmune disorders; Clasp Therapeutics is developing modular T cell engagers tailored to each patient’s immune system that are directed to common oncogenic driver mutations; and more.

Mar 25, 2024, 06:22 by

Mar 25, 2024, 06:22 by

Mar 22, 2024, 07:46 by

Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery

Mar 21, 2024, 07:59 by

ReciBioPharm and GeneVentiv Therapeutics partner to accelerate AAV-based gene therapy for haemophilia patients

Mar 21, 2024, 07:59 by

Mar 21, 2024, 07:59 by

Mar 21, 2024, 05:00 by User Not Found

Clinical Research News | A revolution is underway in the diagnostics world that is reminiscent of what transpired in the computing field before the advent of PCs and smartphones. The unimagined possibilities of today will come from democratizing technology so that instead of sending patients to the lab, the lab will get sent to patients—and, ultimately, be available to them in the form of at-home testing kits.

Mar 20, 2024, 08:29 by

Mar 20, 2024, 08:29 by

Mar 20, 2024, 08:29 by

Mar 20, 2024, 08:29 by

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

Mar 20, 2024, 08:29 by

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Mar 20, 2024, 08:29 by

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Mar 20, 2024, 08:29 by

Mar 20, 2024, 05:00 by User Not Found

Clinical Research News | More than a century has passed since the discovery of insulin, the world's first life-saving treatment for diabetes, and it is still being delivered via injection despite several brushes with success in developing an oral version of the drug. Hope is again on the horizon with the emergence of an oral nanotherapeutic formulation of insulin that comes with the possibility of reducing if not eliminating hypoglycemic events.